Physician profile
Michelle Hall
NPI 1639321227
$2,473.34
in general payments reported to CMS, 2019-2025
19 companies · $570 in 2025
The $570 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $524 · 2022: $538 · 2023: $472 · 2024: $369 · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,411.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $972.87 | 2021-2025 | |
| Allergan, INC. | $275.38 | 2021-2022 | |
| Pfizer INC. | $228.71 | 2022-2025 | |
| Glaxosmithkline, LLC. | $226.06 | 2021-2025 | Arexvy, Shingrix, Penmenvy |
| Horizon Therapeutics Plc | $220.09 | 2021-2022 | |
| Stryker Corporation | $83.90 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $79.48 | 2022 | |
| Bioventus LLC | $69.39 | 2023-2025 | Xcell, Durolane |
| Collegium Pharmaceutical, INC. | $62.11 | 2025 | Belbuca, Xtampza |
| Teleflex LLC | $56.83 | 2021-2025 | Arrow |
| Novartis Pharmaceuticals Corporation | $36.61 | 2023-2024 | |
| Relievant Medsystems, INC. | $28.26 | 2023 | Intracept |
| Ferring Pharmaceuticals INC. | $25.94 | 2025 | Euflexxa |
| Si-Bone, INC. | $23.60 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $18.48 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $17.44 | 2024 | Zilretta, Iovera, Exparel |
| Fidia Pharma USA INC. | $16.97 | 2024 | Hymovis |
| Astrazeneca Pharmaceuticals LP | $15.89 | 2024 | Farxiga |
| Janssen Pharmaceuticals, INC | $15.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.